Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000897069-24-000283
Filing Date
2024-02-08
Accepted
2024-02-08 17:55:37
Documents
1
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2021
  Complete submission text file 0000897069-24-000283.txt   3457
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELOMIR PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address
Fuentes Nathen (Reporting) CIK: 0002005072 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41952 | Film No.: 24610479